Components | CRC | NSCLC | NT | LC | PC | BC | GC | BLC | OC | CC | PTC | EAC | HNSCC | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Base medium | Advanced DMEM/F12 | √ | √ | √ | DMEM-GlutaMAX | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | DMEM/F12 | √ | √ |
HEPES | 1% | 10 mM | 10 mM | 10 mM | 1× | 10 mM | 10 mM | 12 mM | 10 mM | 10 mM | 1× | |||||||
GlutaMAX | 1% | 2 mM | 1% | 1% | 1× | 1× | 2 mM | 1% | 1× | 1× | ||||||||
L-Glutamine | 2 mM | |||||||||||||||||
Penicillin/streptomycin | 1% | √ | 100 μg/mL | 1% | 1% | 1× | 100 μg/mL | √ | 100 units/mL | 1× | ||||||||
N-acetyl-L-cysteine | 10 mM | 1 mM | 1.25 mM | 1.25 mM | 1.25 mM | 1 mM | 1.25 mM | 1 mM | 1.25 mM | 1.25 mM | 1.25 mM | 1 mM | 1.25 mM | |||||
Nicotinamide | 10 mM | 10 mM | 10 mM | 10 mM | 10 mM | 5 mM | 4 mM | 10 mM | 1 mM | 2.5 mM | 10 mM | 100 μM | 10 mM | 10 mM | ||||
B27 | 1× | 1× | 1× | √ | 2% | 2% | 1× | 1× | 1× | 1× | 2% | 2% | 1× | 1× | 0.5× | 1× | 1× | |
Primocin | 100 μg/mL | 1 mg/mL | 50 mg/mL | 100 μg/mL | 1 mg/mL | |||||||||||||
Cytokine | R-Spondin | 1 mg/mL | 500 ng/mL | 500 ng/mL | 4% | |||||||||||||
R-Spondin conditioned medium | 20% | 10% | 10% | 10% | 10% | 10% | 25% | 10% | 20% | |||||||||
Noggin | 25 ng/mL | 100 ng/mL | 100 ng/mL | 100 ng/mL | 100 ng/mL | 100 ng/mL | 25 ng/mL | 0.1 μg/mL | 4% | |||||||||
Noggin conditioned medium | 10% | 10% | 10% | 1% | ||||||||||||||
rmNoggin | 100 ng/mL | |||||||||||||||||
Wnt-3A | 100 ng/mL | |||||||||||||||||
Wnt surrogate | 0.5 nM | |||||||||||||||||
Wnt-3A conditioned medium | 50% | 30% | 50% | 25% | 25% | 50% | ||||||||||||
rhEGF | 50 ng/mL | 20 ng/mL | 50 ng/mL | 50 ng/mL | 50 ng/mL | 5 ng/mL | 10 ng/ mL | 50 ng/μL | 50 ng/mL | |||||||||
EGF | 50 ng/mL | 20 ng/mL | 50 ng/mL | |||||||||||||||
rmEGF | 50 ng/mL | 50 ng/mL | 50 ng/mL | |||||||||||||||
rhHGF | 25 ng/mL | 25 ng/mL | ||||||||||||||||
rhFGF10 | 100 ng/mL | 100 ng/mL | 100 ng/mL | 100 ng/mL | 20 ng/mL | 50 ng/mL | 10 ng/mL | 100 ng/mL | 100 ng/mL | 10 ng/mL | 100 ng/mL | 10 ng/mL | ||||||
FGF | 10 ng/mL | |||||||||||||||||
rhFGF7 | 25 ng/mL | 5 ng/mL | 25 ng/mL | 25 ng/mL | 5 ng/mL | |||||||||||||
FGF2 | 40 ng/mL | 12.5 ng/mL | 20 ng/mL | 5 ng/mL | ||||||||||||||
PDGF-AA | 10 ng/mL | |||||||||||||||||
PDGF-BB | 10 ng/mL | |||||||||||||||||
Small molecule compound | VEGF-121 | 10 ng/mL | ||||||||||||||||
IGF-1 | 200 ng/mL | |||||||||||||||||
Gastrin | 10 nM | 10 nM | 10 nM | 10 nM | 10 nM | 10 nM | 10 nM | |||||||||||
PGE2 | 10 nM | 1 μM | 1 μM | |||||||||||||||
Neuregulin 1 | 5 nM | |||||||||||||||||
SB202190 | 3 μM | 10 μM | 1 μM | 500 nM | 5 μM | 10 μM | 10 μM | |||||||||||
SB431542 | 0.5 μM | |||||||||||||||||
Y-27632 | 5 μM | 10 μM | 10 μM | 5 mM | 10 μM | 10 μM | 9 μM | 10 mM | 10 μM | 10 μM | ||||||||
A83-01 | 500 nM | 500 nM | 500 nM | 5 μM | 5 μM | 0.5 μM | 500 nM | 500 nM | 0.5 μM | 5 μM | 500 nM | 500 nM | 5 μM | 0.5 μM | 500 nM | |||
CHIR 99021 | 0.3 μM | 3 μM | ||||||||||||||||
Other supplements | N2 | √ | 1% | 1% | 1× | 1% | ||||||||||||
Forskolin | 10 μM | 10 μM | 10 mM | 1 μM | ||||||||||||||
β-Estradiol | 100 nM | |||||||||||||||||
DEX | 3 nM | |||||||||||||||||
References | 104,111,112 | 113 | 104 | 114 | 14 | 115,116 | 59 | 82 | 57 | 91 | 9 | 117 | 118 | 119 | 15 | 120 |
NSCLC, non-small cell lung carcinoma; NT, neuroblastoma tumor; EGF, epidermal growth factor; FGF, fibroblast growth factor; IGF, insulin-like growth factor; PDGF, platelet-derived growth factor; LC, liver cancer; PTC, papillary thyroid cancer; VEGF, vascular endothelial growth factor; HNSCC, head and neck squamous cell carcinoma; CC, cervical cancer.